Skip to main content

. 1993 Mar 6;306(6878):621–622. doi: 10.1136/bmj.306.6878.621

Comparison of nifedipine and propranolol as second line agent for hypertension in black Kenyans.

N R Poulter ¹, J E Sanderson ¹, A V Thompson ¹, P S Sever ¹, C L Chang ¹

PMCID: PMC1676947 PMID: 8461812

621

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Hills M., Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol. 1979 Jul;8(1):7–20. doi: 10.1111/j.1365-2125.1979.tb05903.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
Maslowski A. H., Nicholls M. G., Espiner E. A., Ikram H., Bones P. J. Mechanisms in human renovascular hypertension. Hypertension. 1983 Jul-Aug;5(4):597–602. doi: 10.1161/01.hyp.5.4.597. [DOI] [PubMed] [Google Scholar]
Seedat Y. K. Trial of atenolol and chlorthalidone for hypertension in black South Africans. Br Med J. 1980 Nov 8;281(6250):1241–1243. doi: 10.1136/bmj.281.6250.1241. [DOI] [PMC free article] [PubMed] [Google Scholar]
Zing W., Ferguson R. K., Vlasses P. H. Calcium antagonists in elderly and black hypertensive patients. Therapeutic controversies. Arch Intern Med. 1991 Nov;151(11):2154–2162. [PubMed] [Google Scholar]

ACTIONS

RESOURCES